Page last updated: 2024-08-22

n-methylaspartate and Depressive Disorder, Treatment-Resistant

n-methylaspartate has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cook, J; Halaris, A1

Other Studies

1 other study(ies) available for n-methylaspartate and Depressive Disorder, Treatment-Resistant

ArticleYear
Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression.
    Progress in neuro-psychopharmacology & biological psychiatry, 2022, 12-20, Volume: 119

    Topics: Bupropion; Depression; Depressive Disorder, Treatment-Resistant; Dopamine; Humans; Ketamine; N-Methylaspartate

2022